Found: 3
Select item for more details and to access through your institution.
A Strategy for Risk Management of Drug-Induced Phospholipidosis.
- Published in:
- Toxicologic Pathology, 2009, v. 37, n. 7, p. 997, doi. 10.1177/0192623309352496
- By:
- Publication type:
- Article
Correction to: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program.
- Published in:
- American Journal of Clinical Dermatology, 2024, v. 25, n. 2, p. 299, doi. 10.1007/s40257-024-00846-3
- By:
- Publication type:
- Article